BOULDER, Colo., Dec. 1, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Oppenheimer Annual Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO
Event: Oppenheimer Annual Healthcare Conference
Presenter: Ron Squarer, Chief Executive Officer
Date: Wednesday, December 9, 2015
Time: 10:20 a.m. Eastern Time
Webcast: http://www.veracast.com/webcasts/opco/healthcare2015/19204383745.cfm
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Tricia Haugeto Array BioPharma Inc. 303-386-1193 thaugeto@arraybiopharma.com
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-oppenheimer-annual-healthcare-conference-300186263.html
SOURCE Array BioPharma Inc.